NeoGenomics Inc (NEO)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -87,968 | -96,329 | -114,665 | -125,637 | -144,250 | -163,322 | -146,818 | -35,642 | -8,348 | 48,828 | 71,733 | -10,964 | 4,172 | -4,949 | -5,363 | 3,452 | 8,006 | 2,063 | 1,943 | -428 |
| Total assets | US$ in thousands | 1,681,230 | 1,678,240 | 1,695,110 | 1,709,170 | 1,740,030 | 1,755,580 | 1,792,110 | 1,829,550 | 1,869,780 | 1,906,390 | 1,896,310 | 1,494,410 | 988,331 | 959,428 | 945,485 | 732,247 | 709,506 | 711,155 | 696,667 | 533,343 |
| ROA | -5.23% | -5.74% | -6.76% | -7.35% | -8.29% | -9.30% | -8.19% | -1.95% | -0.45% | 2.56% | 3.78% | -0.73% | 0.42% | -0.52% | -0.57% | 0.47% | 1.13% | 0.29% | 0.28% | -0.08% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $-87,968K ÷ $1,681,230K
= -5.23%
Neogenomics Inc.'s return on assets (ROA) has shown a declining trend over the past eight quarters, ranging from -5.23% in Q4 2023 to -1.95% in Q1 2022. The negative values indicate that the company's net income generated from its assets is insufficient to cover its total assets, which may be a cause for concern for investors and stakeholders. The decreasing ROA over time suggests potential inefficiencies in the company's asset utilization or profitability. Further investigation into Neogenomics Inc.'s operational efficiency, profitability, and asset management strategies may be warranted to address the declining ROA trend.